OtoNexus Medical Technologies Selected for Elite FDA STeP Program
FDA STeP Program awarded to OtoNexus Medical Technologies for ultrasound platform technology that evaluates middle ear infections.
SEATTLE, Dec. 6, 2023 /PRNewswire/ — OtoNexus Medical Technologies, the developer of the Novoscope ultrasound otoscope for immediate and automatic differentiation of bacterial middle ear infections, is excited to announce its recent selection into U. S. Food and Drug Administration Safter Technologies Program (STeP).
